• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Nektar Therapeutics (NKTR)

    -NasdaqGS
    11.09 Up 0.18(1.65%) Mar 27, 4:00PM EDT
    |After Hours : 11.09 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:10.91
    Open:10.91
    Bid:N/A
    Ask:12.48 x 1000
    1y Target Est:15.42
    Beta:1.34
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:10.70 - 11.17
    52wk Range:10.10 - 17.53
    Volume:1,771,774
    Avg Vol (3m):1,199,060
    Market Cap:1.46B
    P/E (ttm):N/A
    EPS (ttm):-0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NKTR

    Comparison

    Symbol% ChgMkt Cap
    NKTRUp 1.65%1.46B
    BMYUp 0.40%108.47B
    ENZNDown 0.97%45.07M
    GSKUp 0.77%113.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):7.14
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.39
    Quarterly EPS Est (Mar-15) :-0.40
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):3.69

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback